ARAGONA, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 243
EU - Europa 144
AS - Asia 138
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 527
Nazione #
US - Stati Uniti d'America 241
CN - Cina 70
IE - Irlanda 47
SE - Svezia 46
SG - Singapore 46
IT - Italia 27
IN - India 9
TR - Turchia 8
GB - Regno Unito 6
DE - Germania 4
FI - Finlandia 4
BE - Belgio 3
AT - Austria 2
CZ - Repubblica Ceca 2
IR - Iran 2
SA - Arabia Saudita 2
BG - Bulgaria 1
CA - Canada 1
CI - Costa d'Avorio 1
EU - Europa 1
IL - Israele 1
LT - Lituania 1
NL - Olanda 1
PA - Panama 1
Totale 527
Città #
Chandler 80
Dublin 47
Singapore 40
Ashburn 35
Shanghai 18
Beijing 15
Boardman 14
Nanjing 12
Izmir 7
Princeton 7
New York 6
Pune 6
Wilmington 5
Ann Arbor 4
Bremen 4
Dearborn 4
Helsinki 4
Parma 4
San Mateo 4
Brussels 3
Calenzano 3
Changsha 3
Marnate 3
Mumbai 3
Ningbo 3
Norwalk 3
Santa Clara 3
Bologna 2
Cremona 2
Dallas 2
Dammam 2
Kunming 2
London 2
Nanchang 2
Shenyang 2
Tianjin 2
Vienna 2
Abidjan 1
Amsterdam 1
Andover 1
Atlanta 1
Borgia 1
Chengdu 1
Des Moines 1
Hebei 1
Hefei 1
Jiaxing 1
Kocaeli 1
Leawood 1
Los Angeles 1
Neviano degli Arduini 1
Ottawa 1
Panama City 1
Prague 1
Rome 1
Seattle 1
Sofia 1
Tappahannock 1
Tel Aviv 1
Venice 1
Totale 383
Nome #
42 OP Potential use of lactoferrin in a 7 days triple therapy for helicobacter pylori eradication: A pilot study 67
Quality of life in uncomplicated diverticular disease: Is it another good reason for the treatment? 65
CS1.1 EFFICACY OF MESALAMINE AND THE ASSOCIATION OF MESALAMINE AND PROBIOTICS VERSUS RIFAXIMIN IN THE TREATMENT OF SYMPTOMATIC DIVERTICULAR DISEASE 62
Clinical presentation of 324 patients with hepatocellular carcinoma (HCC) in a single center of North Italy 61
Real-life efficacy and safety of Ustekinumab as second- or third-line therapy in Crohn’s disease: Results from a large Italian cohort study 60
One-week H. Pylori eradication therapy Rabeprezole 20 mg bid vs 10 mg bid 51
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 42
The management of endoscopic retrograde cholangiopancreatography- related infections risk: results of an italian survey at regional level 33
Comparison of Performances of Adalimumab Biosimilars SB5, APB501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study 31
Spyglass percutaneous transhepatic lithotripsy of symptomatic recurrent lithiasis of the intrahepatic bile duct with distal stenosis 23
Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy 22
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn’s disease: results from an Italian multicenter study 20
Totale 537
Categoria #
all - tutte 2.859
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.859


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202016 0 0 0 0 0 3 4 1 0 8 0 0
2020/202115 0 0 0 0 0 0 0 0 8 5 1 1
2021/202244 1 1 0 1 4 0 5 0 4 3 5 20
2022/2023219 14 24 18 23 12 27 1 20 68 5 6 1
2023/2024118 6 10 8 5 10 19 11 23 2 6 8 10
2024/202580 14 15 13 14 24 0 0 0 0 0 0 0
Totale 537